Segment Results (Schedule Of Reportable Segments Information) (Details) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2017 USD ($)	Sep. 30, 2016 USD ($)	Sep. 30, 2017 USD ($) segment	Sep. 30, 2016 USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment			3
Segment Reporting Information [Line Items]
Total net revenues to external customers	$ 786,887	$ 884,335	$ 2,700,218	$ 2,768,761
Total segment adjusted income from continuing operations before income tax	377,955	382,409	1,260,201	1,142,715
U.S. Generic Pharmaceuticals
Segment Reporting Information [Line Items]
Total net revenues to external customers	496,654	533,691	1,781,949	1,682,439
Total segment adjusted income from continuing operations before income tax	236,767	228,717	832,232	655,453
U.S. Branded Pharmaceuticals
Segment Reporting Information [Line Items]
Total net revenues to external customers	233,803	279,843	729,150	876,998
Total segment adjusted income from continuing operations before income tax	123,754	131,615	380,841	422,816
International Pharmaceuticals
Segment Reporting Information [Line Items]
Total net revenues to external customers	56,430	70,801	189,119	209,324
Total segment adjusted income from continuing operations before income tax	$ 17,434	$ 22,077	$ 47,128	$ 64,446